FDA and EMA launch pilot programme to provide scientific advice on complex generic/hybrid products
The pilot programme is an expansion of FDA and EMA’s existing PSA for new drugs and biological products
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.